Disease Management Programs to Promote Early Diagnosis and Treatment of Benign Prostatic Hyperplasia

ISSN： 1173-8790

Source： Disease Management & Health Outcomes, Vol.11, Iss.1, 2003-01, pp. : 7-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of Benign Prostatic Hyperplasia: Defining the Role of Tamsulosin

By Katherine F. Croom Antona J. Wagstaff

Disease Management & Health Outcomes, Vol. 12, Iss. 5, 2004-01 ,pp. : 337-350

Adis International

Access to resources Recommend Favorite

The appropriateness of treatment of benign prostatic hyperplasia: a comparison of Dutch and multinational criteria

By McDonnell J. Stoevelaar H.J. Ruud Bosch J.L.H. Kahan J.P. Members of the Dutch Panels on the Appropriate of BPH Members of the European Panels on the Appropriate Treatment of BPH

Health Policy, Vol. 57, Iss. 1, 2001-07 ,pp. : 45-56

Elsevier

Access to resources Recommend Favorite

Treatment Expectations in Hypertension: Implications for Patients Enrolled in Disease Management Programs

By Cohen D. Townsend R. Miani M. Bernard D.

Disease Management & Health Outcomes, Vol. 9, Iss. 11, 2001-01 ,pp. : 631-640

Adis International

Access to resources Recommend Favorite

Evaluating Disease Management Programs

By Walker D.R. McKinney B.K. Cannon-Wagner M. Vance R.P.

Disease Management & Health Outcomes, Vol. 10, Iss. 10, 2002-01 ,pp. : 613-619

Adis International

Access to resources Recommend Favorite

Translational Pharmacology in Aging Men with Benign Prostatic Hyperplasia: Molecular and Clinical Approaches to Alpha1-Adrenoceptors

Current Aging Science, Vol. 2, Iss. 3, 2009-12 ,pp. : 223-239

Bentham Science Publishers

Access to resources Recommend Favorite